A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 7, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
In-Stent Restenosis
Interventions
DEVICE

AGENT DCB 40 mm

Drug coated PTCA balloon catheter 40 mm size

Trial Locations (11)

10032

Columbia University Medical Center, New York

11576

St. Francis Hospital, Roslyn

17053

UPMC Pinnacle Health, Wormleysburg

30322

Emory University Hospital, Atlanta

37203

Centennial Medical Center, Nashville

45219

Lindner Center for Research and Education at Christ Hospital, Cincinnati

48202

Henry Ford Hospital, Detroit

75226

Baylor Heart and Vascular Hospital, Dallas

85745

Carondelet Medical Group St. Mary's Hospital, Tucson

90048

Cedars Sinai Medical Center, Los Angeles

02903

Rhode Island Hospital, Providence

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY